Skip to main content

Long-term effects of octreotide on markers of bone metabolism in acromegaly: Evidence of increased serum parathormone concentrations

Journal of Endocrinological Investigation volume 20, pages 434–438 (1997)Cite this article

Abstract

The effects of octreotide on biochemical markers of bone turnover were evaluated in patients with active acromegaly. Serum GH, IGF-I and serum and urinary markers of bone metabolism were measured before and after 4 months of treatment in 27 patients (short-term treatment) and after 12 and 24 months of treatment in 15 patients (long-term treatment). In the short-term, octreotide significantly decreased the levels of serum GH, IGF-I, calcium, osteocalcin, carboxyterminal propeptide of type I collagen and alkaline phosphatase plus urinary excretion of calcium. Short-term treatment significantly increased serum parathormone levels (before treatment 30.1 ±9.57 and at 4 months 46.1 ±24.98 ng/L, p<0.001) and urinary excretion of phosphate; urinary excretion of hydroxyproline was unchanged. The same results were observed during long-term treatment, except that there was no significant difference of serum calcium and alkaline phosphatase levels before and after treatment. Parathormone concentrations were still higher at 24 months compared with those prior to treatment (before treatment 31.9±9.74 and at 24 months 44.9±21.18 ng/L, p<0.05). The changes of most bone markers during octreotide therapy can be explained by the decrease of serum GH and IGF-I concentrations. On the other hand, the rise of parathormone concentrations suggests that octreotide has ulterior and long-standing actions on calcium homeostasis: intestinal malabsorption of calcium due to the octreotide could contribute to this secondary hyperparathyroidism. The clinical consequences of these alterations of bone metabolism need to be further clarified.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

References

  1. Inzucchi S.E., Robbins J. Effects of growth hormone on human bone biology. J. Clin. Endocrinol. Metab. 79: 691, 1994.

    CAS  PubMed  Google Scholar 

  2. Ezzat S., Melmed S., Endres D., Eyre D., Singer F. Biochemical assessment of bone formation and resorption in acromegaly. J. Clin. Endocrinol. Metab. 76: 1452, 1993.

    CAS  PubMed  Google Scholar 

  3. Takamoto S., Tsuchiya H., Onishi T., Morimoto S., Imanaka S., Mori S., Seino Y., Uozumi T., Kumahara Y. Changes in calcium homeostasis in acromegaly treated by pituitary adenomectomy. J. Clin. Endocrinol. Metab. 61: 7, 1985.

    CAS  PubMed  Article  Google Scholar 

  4. Johansen J.S., Pederson S.A., Jorgensen J.O.L., Riis B.J., Christiansen C., Christiansen J.S., Skakkebaek Ne. Effects of growth hormone (GH) on plasma bone Gla protein in GH-deficient adults. J. Clin. Endocrinol. Metab. 70: 916, 1990.

    CAS  PubMed  Article  Google Scholar 

  5. Marazuela M., Astigarraga B., Tabuenca M.J., Estrada J., Marin F., Lucas T. Serum bone GLA protein as a marker of bone turnover in acromegaly. Calcif. Tissue Int. 52: 419, 1993.

    CAS  PubMed  Article  Google Scholar 

  6. Eskildsen P.C., Lund B., Sorensen O.H., Lund B., Bishop J.E., Norman A.W. Acromegaly and vitamin D metabolism: effect of bromocriptine treatment. J. Clin. Endocrinol. Metab. 49: 484, 1979.

    CAS  PubMed  Article  Google Scholar 

  7. Legovini P., De Menis E., Doroldi C., Carteri A., Billed D., Roiter I., Breda F., Conte N. Parathormone levels during treatment of acromegaly with octreotide: one-year follow-up. Curr. Ther. Res. 53: 360, 1993.

    Article  Google Scholar 

  8. Kanis J., Yates A. Measuring serum calcium. Br. Med. J. 290: 728, 1985.

    CAS  Article  Google Scholar 

  9. Sigurdsson G., Nunziata V., Reiner M., Nadarajah A., Joplin G.F. Calcium absorption and excretion in the gut in acromegaly. Clin. Endocrinol. 2: 187, 1973.

    CAS  Article  Google Scholar 

  10. Halse J., Haugen H.N. Calcium and phosphate metabolism in acromegaly. Acta Endocrinol. 94: 459, 1980.

    CAS  PubMed  Google Scholar 

  11. Lund B., Eskildsen P.C., Lund B., Norman A.W., Sorensen O.H. Calcium and vitamin D metabolism in acromegaly. Acta Endocrinol. 96: 444, 1981.

    CAS  PubMed  Google Scholar 

  12. Spanos E., Barrett D., Maclntyre I., Pike J.W., Safilian E.F., Haussler M.R. Effect of growth hormone on vitamin D metabolism. Nature 273: 246, 1978.

    CAS  PubMed  Article  Google Scholar 

  13. Spencer E.M., Tobiassen O. The mechanism of the action of growth hormone on vitamin D metabolism in the rat. Endocrinology 108: 1064, 1981.

    CAS  PubMed  Article  Google Scholar 

  14. Corvilain J., Abramow M. Some effects of human growth hormone on renal hemodynamics and on tubular phosphate transport in man. J. Clin. Invest. 41: 1230, 1962.

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  15. Camanni F., Massara F., Losana O., Molinatti G.M. Increased renal tubular reabsorption of phosphate in acromegaly. J. Clin. Endocrinol. Metab. 28: 999, 1968.

    CAS  PubMed  Article  Google Scholar 

  16. Canalis E., Lian J.B. Effects of bone associated growth factors on DNA, collagen and osteocalcin synthesis in cultured fetal rat calvariae. Bone 9: 243, 1980.

    Article  Google Scholar 

  17. Skjodt H., Gallangher J.A., Berensford J.N. Vitamin D metabolites regulate osteocalcin synthesis and proliferation of human bone cells in vitro. J. Endocrinol. 61: 391, 1985.

    Article  Google Scholar 

  18. De la Piedra C., Carbo E., Larranaga J., Castro N., Horcajada C., Rapado A., Herrera Pombo J.L. Correlation among plasma osteocalcin, growth hormone, and somatomedin C in acromegaly. Calcif. Tissue Int. 43: 44, 1988.

    PubMed  Article  Google Scholar 

  19. Piovesan A., Terzolo M., Reimondo G., Pia A., Codegone G., Osella G., Boccuzzi A., Paccotti P., Angeli A. Biochemical markers of bone and collagen turnover in acromegaly or Cushing’s syndrome. Horm. Metab. Res. 26: 234, 1994.

    CAS  PubMed  Article  Google Scholar 

  20. Fredstorp L., Pernow Y., Wener S. The short and long-term effects of octreotide on calcium homeostasis in patients with acromegaly. Clin. Endocrinol. 39: 331, 1993.

    CAS  Article  Google Scholar 

  21. Deftos L.J., Lorenzi M., Bohanon N., Tsalakian E., Schneider V., Gerich J.E. Somatostatin does not suppress plasma parathyroid hormone. J. Clin. Endocrinol. Metab. 43: 205, 1976.

    CAS  PubMed  Article  Google Scholar 

  22. Scholz D., Schwille P.O. Somatostatin and intestinal calcium absorption in man. Metabolism 27(Suppl. 1): 1349, 1978.

    CAS  PubMed  Article  Google Scholar 

  23. Hargis G.K., Williams G.A., Reynolds A., Chertow B.S., Kukreja S.C., Bowser N., Henderson W.J. Effect of somatostatin on parathyroid hormone and calcitonin secretion. Endocrinology 102: 745, 1978.

    CAS  PubMed  Article  Google Scholar 

  24. Botana M.A., Castillo L., Pesquera C., Freijanes J., Amado J.A., Gonzalez-Macias J. Lack of effect of octreotide on parathyroid hormone levels and urinary excretion of epidermal growth factor. Horm. Metab. Res. 25: 37, 1993.

    CAS  PubMed  Article  Google Scholar 

  25. Terzolo M., Piovesan A., Osella., Pia A., Reimondo G., Pozzi C., Raucci C., Torta M., Paccotti P., Angeli A. Serum levels of bone GLA protein (osteocalcin, BGP) and carboxyterminal propeptide of type I Procollagen (PICP) in acromegaly: effects of long-term octreotide treatment. Calcif. Tissue Int. 52: 188, 1993.

    CAS  PubMed  Article  Google Scholar 

  26. Kotzman H., Bernecker P., Hubsh P., Pietschmann P., Woloszczuk W., Svoboda T., Geyer G., Luger A. Bone mineral density and parameters of bone metabolism in patients with acromegaly. J. Bone Miner. Res. 8: 459, 1993.

    Article  Google Scholar 

Download references

Author information

Affiliations

  1. I Divisione Medica, Ospedale Regionale, 31100, Treviso, Italy

    Pietro Legovini, E. De Menis, F. Breda, P. Pavan & N. Conte

  2. Divisione di Neurochirurgia, Ospedale Regionale, Treviso, Italy

    D. Billeci & A. Carteri

Authors
  1. Pietro Legovini
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. De Menis
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. F. Breda
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D. Billeci
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. Carteri
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. P. Pavan
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. N. Conte
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Legovini, P., De Menis, E., Breda, F. et al. Long-term effects of octreotide on markers of bone metabolism in acromegaly: Evidence of increased serum parathormone concentrations. J Endocrinol Invest 20, 434–438 (1997). https://doi.org/10.1007/BF03347998

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03347998

Key-words

  • Agromegaly
  • octreotide
  • bone
  • bone markers
  • osteocalcin
  • parathormone